Eileen McCormack
Fortune : 60 762 $ au 31/07/2026
Fortune : 60 762 $ au 31/07/2026
Eileen McCormack worked at AstraZeneca PLC from 2014 to 2017 as Head-New Product Planning & Business Development.
Ms. McCormack worked at Avicanna, Inc. from 2022 to 2026 as Independent Director.
Ms. McCormack completed undergraduate and graduate degrees at the University of Guelph.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVICANNA INC 0,52 % | 27/05/2025 | 653 356 ( 0,52 % ) | 60 762 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| AVICANNA INC. | Directeur/Membre du Conseil | 01/05/2026 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avicanna, Inc.
Avicanna, Inc. BiotechnologyHealth Technology Develops, manufactures and supplies plant-derived cannabinoid-based products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national